{"name":"Quell Therapeutics Limited","slug":"quell-therapeutics-limited","ticker":"","exchange":"","domain":"quell.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNUGZUSUxJXzQ4cnlwZ2tUS09wYjZyNHJ6cVJucFdXODA1U1N1cE90QWhFTDB3emVxcS1KazlPb2RZMExCYUh3eExvU1hic0JuSlF6dnB0VUdMQTdTVVVOTXJPQTFoMTVjY20zSHZnME9Pblh5N2JJZ3M3TktzYXpDOVFWZWp3RTRPcFpKUEJMMFhlRFo2bTFj?oc=5","date":"2026-03-03","type":"trial","source":"PharmaTimes","summary":"Quell launches chill phase 1/2 trial for novel cartreg therapy - PharmaTimes","headline":"Quell launches chill phase 1/2 trial for novel cartreg therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQLWNtLVltRWpMbEhxWWR1X2NEOGFOVDEwU3QxSVdQcjRyRkRnMXd3cHlYMnVjMGhCQUVWZzJ6WmhEaUJvNUtLT3VfTk8tSGN4MmFiQmRtR0hKLWhBSnBudHF3SG1OMTAxdEJOMVE0R0U1Y1YyVkM2czZfazJHNHJPZkFaQlloUXJYTml0REhR?oc=5","date":"2026-03-03","type":"trial","source":"pharmaphorum","summary":"Quell takes new Treg into clinic after transplant study halt - pharmaphorum","headline":"Quell takes new Treg into clinic after transplant study halt","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi2gJBVV95cUxQT1VTd3JKOTA0a1I1bW9icndWQUlXdUxtWDAxcUdNQi1ZZTZkWXQ1amhmdW4tNjFYbzcyVElBa3UzLXRTY24zOVdUVWNYeTAtRTlaMTJpYi1EZTdwbXpQYWtwQkZxTmZHTmxXNEllSjZtOTBtZzNCcElUSndMYU94WFRfTnZwUWFxQXU4QTM3OHZIQnpuT3BsVWR5RV9iMUg5aGNCVmxxTkxfUTBUQ1k0R040V0tfYjlOMDFlamFPb0pfSjdPNGN4Q3pKbG5ZXzhKdlRhTFhKZmZjS2tpQ3lZdVpuN2w4VEhLQVZhZ05ISVlvY0pKc2pqX1NHMHZfVzdwTWVjWEI5SE9wcXJnZ0hlUW95V3lBZXFuWkVydnJKNWNzMnRheTFSc0VWUDg2U0FUMGZuWHIzZm9kUEZKV241Rmdab2todmZPSThzTGRLSTRqMWN3ekpCU2J3?oc=5","date":"2026-03-03","type":"pipeline","source":"globenewswire.com","summary":"Quell Therapeutics Demonstrates Safety, Phenotypic - globenewswire.com","headline":"Quell Therapeutics Demonstrates Safety, Phenotypic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxNdnF0eEMybTlyVW03RVhTbVVIUmM5Tnh1MVZKNTg4eW5HYVlmOUhTNEMxS0RUdm1SWDV2aE1CcHdacFowYm5fcXM0bWRrcmI4NUZ3TzV2bElpa0swbGhKVllabnpJR3RlWXUyT05jOEtoeXFSaDdvUDBSWWNZYnRWYkVla1NObU8yX0ZIazF3UFRLT3pRU0FNa3ZuOFd2ekwxdHJZeGhOS1pFNTVqM0pDanNoTjFuVkV4SGljOGhLaEZETkFXVE0zU3JEaTR2MElQMjNQMDZ0UXBvRlVYd1F0cFBHdlJOYnRUeDdsZ3F5LXg3RVU5MWZicHFXWjh0QWNwS2poWDlZMjVlNHF6UTdEdExNaW53R3ZwMEk0MnpVdmRsS29yaFpBei1MaGdZOXJvNFJNeWR4VmdmclduSjFqZm43TGROZGh2Y3JveEZ2T0NPUFJ1T3BXQ3NpaUc?oc=5","date":"2026-03-03","type":"regulatory","source":"globenewswire.com","summary":"Quell Therapeutics Initiates CHILL Phase 1/2 Trial of Novel QEL-005 CAR-Treg Therapy in Refractory Rheumatoid Arthritis and Systemic Sclerosis Following UK CTA Approval - globenewswire.com","headline":"Quell Therapeutics Initiates CHILL Phase 1/2 Trial of Novel QEL-005 CAR-Treg Therapy in Refractory Rheumatoid Arthritis ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPYkhRUFMxbGtfclh3YXRvcGZsUjhYYnRpZS1LVmd2RTM5NVlBSmx2bkMtdTJMX29iSjZ2OFFzTmI2ZjJJQ1A1UVdENXVQRkpyRlF0UlR2RERzQngwUWc2N1VLMi1LdHlJZkVMSnVsX3NXYlk5T0tlYXJlS2I2OUFXdjJzeFRDRjVUVmN4SQ?oc=5","date":"2026-01-27","type":"pipeline","source":"pharmaphorum","summary":"Introducing the Sunday Times Tech 100: Life sciences part 2 - pharmaphorum","headline":"Introducing the Sunday Times Tech 100: Life sciences part 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPYTl1bUxVLWNULTRha21IX0QtdWh3bHY4ZmNJcklBTGZhZzlpZTIxdWdINDFyMnlUU21Hd2tfN2llMy0xOEJRd2RtdGFPOHJPcGN1LUZDS3UxMG43SGRZYlhGUnFJMDY2eHowU0pGOFZSSEs3TUp2bjRQQ1U5WHh6U2pxM0c0V3lXNUczM3Y0YTVSdDYzU2t6Q1JGenpZaXJuTW9YcWtUTzNENm5a?oc=5","date":"2025-06-10","type":"deal","source":"The Pharma Letter","summary":"Quell Therapeutics achieves key milestone with AstraZeneca deal - The Pharma Letter","headline":"Quell Therapeutics achieves key milestone with AstraZeneca deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQdTFDLVU3SjBXOHJjTnhoMklVRTZPdkkxamc4MHUzZ3htYWtoTExsY0xtNUh3UTloelFwRmEyZVpJRmZqblNvcTZhREFhOXFoWXc4UUs3aHdZN2RIcXhlMHR2U3pVMlBWQldCUE1lVk9DUU5oS0p2V01kZUFLb2NPOTFxZGF5amM0eHRvN19HQlF4eWhs?oc=5","date":"2025-06-10","type":"pipeline","source":"Yahoo Finance UK","summary":"Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease - Yahoo Finance UK","headline":"Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQSjVvVGFEbW91SG52YU1mYjUybUdRTEhubHNDdE9qZjktV3ZuQ1FGbmJQQ2dHOW1oVGNlYTA5aC1nYmtabm9mbVhVWm5qb1VWcFEydGlaRmE2dXpvMXN0ZUdxTGdJYTd2V1dqZXFPdmlUNkhiQXByelpPQk5mcUhWNGxiTEM1OGExX1QwRHdQOG1fTE5WbVRqeUJ4Zk9ick1nR1JXQ2xvTnNJeG5DUC1GY1lZcC1pZmlDZkxXb2NoUWd6RnVH?oc=5","date":"2025-05-15","type":"deal","source":"Contract Pharma","summary":"AGC Biologics Partners with Quell Therapeutics for Treg Cell Therapy Development - Contract Pharma","headline":"AGC Biologics Partners with Quell Therapeutics for Treg Cell Therapy Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWXZuNU9QZ3pjN1BzOVk0OW9MM0ViR05PdEdoNEF2V0pZZWw5YUYxcktMSTFKMl9ZclFZOXRoRjRFNW9QWE1YYVg5clc2emthZ0xPaDA4S243UGtGRXVKNWRvTFZQT0s1RkRDZlRjV09jbTliRW53cmlzNk5HMjZCcHJubFZTSDMxTlhEaHY3MHM4d0FSV3ViWk5uVmxpbkJUcXpJRlFDR203eXRZaWc3OS1qNFlCb2FNeGhLNkZNZmUzTVE?oc=5","date":"2024-11-18","type":"deal","source":"Pharmaceutical Technology","summary":"AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership - Pharmaceutical Technology","headline":"AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPdk5CWjNlaXp4ZnRSeTJBQUc2bjBDbDZFa2FfcUhVakFkWFpkc0dhN2tIWWkwNTlPRTkzV1lOTGhRWWdHZ3RzWFA4eTlYODd1aWpJbXY1S0dUTXlDbUpsNnNMUUFzTlQwaDRZb2stNzJ0MHBVM1ktRHVoV3d3bFl4UTh5VUJPa192NVcwNzhIWWd5c3hCTkJoQktCT1Nxb21oWHQ5ODNjb0MzSWU0WF9aQUsxYzlDYTBZTklOaUk5YmpWSDJGY2pGSTVaTy1WYnpUTFRtZER2eU1RTzRhYzJTODJXWlkxeFZ5TFBZeTlrbUZzNnM?oc=5","date":"2024-09-30","type":"deal","source":"Technology Networks","summary":"Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership With eXmoor Pharma - Technology Networks","headline":"Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership With eXmoor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOLWtwMTAyNE83bmVtZmNlQXlfU0JYUDRwcUdoUmtmR3FsRVpiR3lMQzY4VjZLUXlFUEw3ZlNiejVfb2lCWHFneFJ0OGRmSWV1cDVRMEg0UFlhOVR3OFVCSjZ4TVZZUURmQjU3QVNkRUNTQi1HZmpRYVktZmhMTkxtcDBubVZYR3BZWXBPYjFUOWMyMHVFOW1FeGJPRFZod1lQU2ZOVnNaMkJPRGFCQlNONA?oc=5","date":"2023-06-09","type":"regulatory","source":"AstraZeneca","summary":"AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases - AstraZeneca","headline":"AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulator","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOVENXRjJ6eXpWTXJLaG44UldvNUVWMjZJckY1QzNfMk5BenpNNGlzTERMNlNOZGtacGh1NzlSaG5KUkU4WTZSOTExeFFLRUhSYjZvWW5mYjRMb2RNY2xaMVg4Z1ZMcG1OVUFXOElxVERoYlJrRUxzMWpfcWN5YTFyNHR1MkZjclpLMkI5VHZ6U2w?oc=5","date":"2023-06-09","type":"pipeline","source":"BioPharma Dive","summary":"AstraZeneca teams up with startup Quell, joining ‘Treg’ cell therapy hunt - BioPharma Dive","headline":"AstraZeneca teams up with startup Quell, joining ‘Treg’ cell therapy hunt","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}